(NASDAQ:BLUE) traded lower for the fourth straight session as Bank of America and J.P. Morgan downgraded the gene therapy developer after its Q3 2024 results fell short of expectations for ...
With 2025 on the horizon, investors are sharpening their focus on the year ahead, selecting portfolio additions that aim to bring solid ...
Klarna Group Plc is asking banks to submit pitches in the coming days for junior roles as the Swedish fintech firm presses ...
Oil prices remained under pressure this week as demand concerns continue to dominate the narrative in the oil market despite steep inventory draws.
Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 8.96% of ...
JPMorgan is assessing options for its European headquarters in London as the fast-expanding Wall Street bank outgrows its ...
J.P. Morgan Chase is focused on supporting the growth of companies along the Front Range of the Rockies by advising on ...
President-elect Donald Trump ruled out giving a post to JPMorgan Chase & Co.’s Jamie Dimon in his second-term administration ...
JPMorgan CEO Jamie Dimon said Wall Street is buzzing at the prospect of Trump deregulating the banking industry and making it ...
J.P. Morgan is targeting tech startups as clients after Silicon Valley Bank, First Republic Bank and Silvergate Bank ...
JP Morgan Chase &Co, has set up a unit to develop derivative products in India's newest international hub. This venture is ...